Table of Contents

2019-2024 Global Gabapentin Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Gabapentin Consumption 2014-2024
  • 2.1.2 Gabapentin Consumption CAGR by Region
• 2.2 Gabapentin Segment by Type
  • 2.2.1 Capsule
  • 2.2.2 Tablet
• 2.3 Gabapentin Consumption by Type
  • 2.3.1 Global Gabapentin Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Gabapentin Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Gabapentin Sale Price by Type (2014-2019)
• 2.4 Gabapentin Segment by Application
  • 2.4.1 Epilepsy
  • 2.4.2 Neuropathic Pain
  • 2.4.3 Restless Legs Syndrome
  • 2.4.4 Others
• 2.5 Gabapentin Consumption by Application
  • 2.5.1 Global Gabapentin Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Gabapentin Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Gabapentin Sale Price by Application (2014-2019)

3 Global Gabapentin by Players

• 3.1 Global Gabapentin Sales Market Share by Players
  • 3.1.1 Global Gabapentin Sales by Players (2017-2019)
  • 3.1.2 Global Gabapentin Sales Market Share by Players (2017-2019)
• 3.2 Global Gabapentin Revenue Market Share by Players
  • 3.2.1 Global Gabapentin Revenue by Players (2017-2019)
  • 3.2.2 Global Gabapentin Revenue Market Share by Players (2017-2019)
• 3.3 Global Gabapentin Sale Price by Players
• 3.4 Global Gabapentin Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Gabapentin Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Gabapentin Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Gabapentin by Regions

• 4.1 Gabapentin by Regions
  • 4.1.1 Global Gabapentin Consumption by Regions
  • 4.1.2 Global Gabapentin Value by Regions
• 4.2 Americas Gabapentin Consumption Growth
• 4.3 APAC Gabapentin Consumption Growth
• 4.4 Europe Gabapentin Consumption Growth
• 4.5 Middle East & Africa Gabapentin Consumption Growth

5 Americas

• 5.1 Americas Gabapentin Consumption by Countries
  • 5.1.1 Americas Gabapentin Consumption by Countries (2014-2019)
  • 5.1.2 Americas Gabapentin Value by Countries (2014-2019)
• 5.2 Americas Gabapentin Consumption by Type
• 5.3 Americas Gabapentin Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Gabapentin Consumption by Countries
  • 6.1.1 APAC Gabapentin Consumption by Countries (2014-2019)
  • 6.1.2 APAC Gabapentin Value by Countries (2014-2019)
• 6.2 APAC Gabapentin Consumption by Type
• 6.3 APAC Gabapentin Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Gabapentin by Countries
  • 7.1.1 Europe Gabapentin Consumption by Countries (2014-2019)
  • 7.1.2 Europe Gabapentin Value by Countries (2014-2019)
• 7.2 Europe Gabapentin Consumption by Type
• 7.3 Europe Gabapentin Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Gabapentin by Countries
  • 8.1.1 Middle East & Africa Gabapentin Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Gabapentin Value by Countries (2014-2019)
• 8.2 Middle East & Africa Gabapentin Consumption by Type
• 8.3 Middle East & Africa Gabapentin Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Gabapentin Distributors
• 10.3 Gabapentin Customer

11 Global Gabapentin Market Forecast

• 11.1 Global Gabapentin Consumption Forecast (2019-2024)
• 11.2 Global Gabapentin Forecast by Regions
  • 11.2.1 Global Gabapentin Forecast by Regions (2019-2024)
  • 11.2.2 Global Gabapentin Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Gabapentin Forecast by Type
• 11.8 Global Gabapentin Forecast by Application

12 Key Players Analysis

• 12.1 Pfizer
  • 12.1.1 Company Details
  • 12.1.2 Gabapentin Product Offered
  • 12.1.3 Pfizer Gabapentin Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Pfizer News
• 12.2 Depomed
  • 12.2.1 Company Details
  • 12.2.2 Gabapentin Product Offered
  • 12.2.3 Depomed Gabapentin Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Depomed News
• 12.3 TEVA
  • 12.3.1 Company Details
  • 12.3.2 Gabapentin Product Offered
  • 12.3.3 TEVA Gabapentin Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 TEVA News
• 12.4 Mylan
  • 12.4.1 Company Details
  • 12.4.2 Gabapentin Product Offered
  • 12.4.3 Mylan Gabapentin Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Mylan News
• 12.5 Arbor Pharma
  • 12.5.1 Company Details
  • 12.5.2 Gabapentin Product Offered
  • 12.5.3 Arbor Pharma Gabapentin Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Arbor Pharma News
• 12.6 Novartis
  • 12.6.1 Company Details
  • 12.6.2 Gabapentin Product Offered
  • 12.6.3 Novartis Gabapentin Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Novartis News
• 12.7 Apotex
  • 12.7.1 Company Details
  • 12.7.2 Gabapentin Product Offered
  • 12.7.3 Apotex Gabapentin Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Apotex News
• 12.8 Sun Pharmaceutical
  • 12.8.1 Company Details
  • 12.8.2 Gabapentin Product Offered
  • 12.8.3 Sun Pharmaceutical Gabapentin Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Sun Pharmaceutical News
• 12.9 Aurobindo Pharma
  • 12.9.1 Company Details
  • 12.9.2 Gabapentin Product Offered
  • 12.9.3 Aurobindo Pharma Gabapentin Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Aurobindo Pharma News
• 12.10 Intas
  • 12.10.1 Company Details
  • 12.10.2 Gabapentin Product Offered
  • 12.10.3 Intas Gabapentin Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Intas News
• 12.11 Amneal
• 12.12 Marksans Pharma
• 12.13 Glenmark
• 12.14 Alkem
• 12.15 Jiangsu Enhua
• 12.16 Jiangsu Hengrui
• 12.17 Sailike

13 Research Findings and Conclusion

Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.
Gabapentin was originally marketed under the brand name Neurontin and since it became generic, it has been marketed under many other brand names. An extended-release formulation of gabapentin for once-daily administration was introduced in 2011 for postherpetic neuralgia under the brand name Gralise.
Gabapentin is used primarily to treat seizures and neuropathic pain. It is also commonly prescribed for many off-label uses, such as treatment of anxiety disorders, insomnia, and bipolar disorder. There are, however, concerns regarding the quality of the trials conducted and evidence for some such uses, especially in the case of its use as a mood stabilizer in bipolar disorder.

According to this study, over the next five years the Gabapentin market will register a 1.6% CAGR in terms of revenue, the global market size will reach US$ 1550 million by 2024, from US$ 1430 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Gabapentin business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Gabapentin market by product type, application, key manufacturers and key regions and countries.

This study considers the Gabapentin value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Capsule
Tablet
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Epilepsy
Neuropathic Pain
Restless Legs Syndrome
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
Depomed
TEVA
Mylan
Arbor Pharma
Novartis
Apotex
Sun Pharmaceutical
Aurobindo Pharma
Intas
Amneal
Marksans Pharma
Glenmark
Alkem
Jiangsu Enhua
Jiangsu Hengrui
Sailike

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Gabapentin consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Gabapentin market by identifying its various subsegments.
Focuses on the key global Gabapentin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Gabapentin with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Gabapentin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.